Bionano Genomics (NasdaqCM:BNGO) Q1 2026 Earnings call May 13, 2026 04:30 PM ET Company ParticipantsAl Luderer - Appointed Interim President and CEOMark Adamchak - Principal Accounting OfficerWebb Campbell - VPConference Call ParticipantsYi Chen - Managing Director and Senior Healthcare AnalystOperatorGood day and welcome to the Bionano First Quarter 2026 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb Campbell from Gilmartin Gro ...